China · Delayed Price · Currency is CNY Frontier Biotechnologies Statistics
Total Valuation
SHA:688221 has a market cap or net worth of CNY 6.32 billion. The enterprise value is 5.83 billion.
| Market Cap | 6.32B |
| Enterprise Value | 5.83B |
Important Dates
The next confirmed earnings date is Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688221 has 374.58 million shares outstanding. The number of shares has decreased by -0.62% in one year.
| Current Share Class | 374.58M |
| Shares Outstanding | 374.58M |
| Shares Change (YoY) | -0.62% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 14.65% |
| Owned by Institutions (%) | 16.93% |
| Float | 222.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 702.13 |
| PS Ratio | 16.72 |
| PB Ratio | 6.11 |
| P/TBV Ratio | 6.86 |
| P/FCF Ratio | 146.92 |
| P/OCF Ratio | 120.30 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 135.59 |
Financial Position
The company has a current ratio of 4.96, with a Debt / Equity ratio of 0.41.
| Current Ratio | 4.96 |
| Quick Ratio | 4.47 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.75 |
| Interest Coverage | -3.60 |
Financial Efficiency
Return on equity (ROE) is -2.10% and return on invested capital (ROIC) is -1.44%.
| Return on Equity (ROE) | -2.10% |
| Return on Assets (ROA) | -1.20% |
| Return on Invested Capital (ROIC) | -1.44% |
| Return on Capital Employed (ROCE) | -2.17% |
| Weighted Average Cost of Capital (WACC) | 8.57% |
| Revenue Per Employee | 1.43M |
| Profits Per Employee | -82,154 |
| Employee Count | 265 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.51 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.15% in the last 52 weeks. The beta is 0.87, so SHA:688221's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +17.15% |
| 50-Day Moving Average | 18.56 |
| 200-Day Moving Average | 20.72 |
| Relative Strength Index (RSI) | 45.27 |
| Average Volume (20 Days) | 13,231,073 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688221 had revenue of CNY 378.04 million and -21.77 million in losses. Loss per share was -0.06.
| Revenue | 378.04M |
| Gross Profit | 281.47M |
| Operating Income | -32.64M |
| Pretax Income | -21.77M |
| Net Income | -21.77M |
| EBITDA | -15.16M |
| EBIT | -32.64M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 906.67 million in cash and 419.42 million in debt, with a net cash position of 487.25 million or 1.30 per share.
| Cash & Cash Equivalents | 906.67M |
| Total Debt | 419.42M |
| Net Cash | 487.25M |
| Net Cash Per Share | 1.30 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 2.76 |
| Working Capital | 952.75M |
Cash Flow
In the last 12 months, operating cash flow was 52.53 million and capital expenditures -9.52 million, giving a free cash flow of 43.01 million.
| Operating Cash Flow | 52.53M |
| Capital Expenditures | -9.52M |
| Depreciation & Amortization | 17.48M |
| Net Borrowing | 84.69M |
| Free Cash Flow | 43.01M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 74.45%, with operating and profit margins of -8.63% and -5.76%.
| Gross Margin | 74.45% |
| Operating Margin | -8.63% |
| Pretax Margin | -5.76% |
| Profit Margin | -5.76% |
| EBITDA Margin | -4.01% |
| EBIT Margin | -8.63% |
| FCF Margin | 11.38% |
Dividends & Yields
SHA:688221 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.62% |
| Shareholder Yield | 0.62% |
| Earnings Yield | -0.34% |
| FCF Yield | 0.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:688221 has an Altman Z-Score of 5.23 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.23 |
| Piotroski F-Score | 5 |